Viking Therapeutics Ownership | Who Owns Viking Therapeutics?
Viking Therapeutics Ownership Summary
Viking Therapeutics is owned by 77.57% institutional investors, 5.96% insiders, and 16.47% retail investors. Fmr is the largest institutional shareholder, holding 15.99% of VKTX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.61% of its assets in Viking Therapeutics shares.
VKTX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Viking Therapeutics | 77.57% | 5.96% | 16.47% |
Sector | Healthcare Stocks | 47.31% | 8.01% | 44.69% |
Industry | Biotech Stocks | 45.43% | 7.81% | 46.75% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Fmr | 16.54M | 15.99% | $876.80M |
Vanguard group | 10.10M | 9.76% | $535.26M |
Blackrock | 6.03M | 5.82% | $319.45M |
State street | 5.12M | 4.95% | $271.54M |
Jpmorgan chase | 2.25M | 2.18% | $119.36M |
Geode capital management | 1.86M | 1.80% | $98.58M |
Susquehanna group, llp | 1.40M | 1.36% | $74.46M |
Pictet asset management sa | 1.38M | 1.34% | $73.23M |
Viking global investors lp | 1.35M | 1.31% | $71.80M |
Alliancebernstein | 1.24M | 1.20% | $65.79M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Artia global partners lp | 452.98K | 4.64% | $24.01M |
Nationale-nederlanden powszechne towarzystwo emerytalne | 520.08K | 4.48% | $27.57M |
Sassicaia capital advisers | 19.50K | 4.18% | $1.03M |
Apis capital advisors | 100.00K | 3.91% | $5.30M |
Profit investment management | 100.22K | 3.33% | $5.31M |
5am venture management | 237.56K | 2.82% | $12.59M |
Altium capital management lp | 122.00K | 2.64% | $6.47M |
Boone capital management | 174.77K | 2.42% | $9.26M |
Dafna capital management | 189.12K | 2.40% | $10.03M |
Braidwell lp | 1.11M | 1.84% | $58.68M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Vanguard group | 10.10M | 0.01% | 2.31M |
State street | 5.12M | 0.01% | 1.80M |
Jpmorgan chase | 2.25M | 0.01% | 1.21M |
Susquehanna group, llp | 1.40M | 0.01% | 1.12M |
Toms capital investment management lp | 763.60K | 1.52% | 763.60K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Avoro capital advisors | - | - | -3.59M |
Blackrock | 6.03M | 0.01% | -2.25M |
Rokos capital management llp | - | - | -797.90K |
Caption management | - | - | -612.50K |
American century companies | 273.45K | 0.01% | -558.68K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Toms capital investment management lp | 763.60K | 1.52% | 763.60K | $40.48M |
Norges bank | 182.37K | 0.00% | 182.37K | $9.67M |
Renaissance | 159.40K | 0.01% | 159.40K | $8.45M |
Discovery capital management, llc / ct | 146.90K | 1.00% | 146.90K | $7.79M |
Melqart asset management (uk) | 114.95K | 0.50% | 114.95K | $6.09M |
Sold Out
Holder | Change |
---|---|
Scarborough advisors | -10.00 |
Main street group | -10.00 |
Institutional & family asset management | -14.00 |
Parallax volatility advisers | -16.00 |
Innealta capital | -28.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 428 | 0.71% | 80,251,574 | 0.48% | 77 | 1.08% | 247 | -12.72% | 111 | 24.72% |
Mar 31, 2024 | 425 | 93.18% | 79,870,257 | 4.63% | 84 | 1.29% | 283 | 154.96% | 89 | 71.15% |
Dec 31, 2023 | 220 | 8.91% | 76,339,364 | -1.05% | 80 | 1.33% | 111 | 14.43% | 52 | 1.96% |
Sep 30, 2023 | 202 | -8.60% | 77,149,933 | 3.15% | 77 | 0.86% | 97 | -17.09% | 51 | -3.77% |
Jun 30, 2023 | 221 | 4.25% | 74,791,355 | 12.55% | 95 | 1.33% | 117 | -4.10% | 53 | 8.16% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl S | 5.14M | 4.61% | 31.99K |
Fidelity Growth Compy Commingled Pl O | 5.10M | 4.61% | 70.32K |
Fidelity Growth Company Fund | 3.78M | 3.40% | 47.87K |
Vanguard Total Stock Mkt Idx Inv | 3.32M | 2.98% | 2.50K |
SPDR® S&P Biotech ETF | 2.80M | 2.51% | 30.95K |
Vanguard Small Cap Index | 2.63M | 2.36% | -14.28K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.66M | 1.49% | -30.68K |
Vanguard Small Cap Growth Index Inv | 1.45M | 1.30% | -12.03K |
Fidelity Growth Company K6 | 1.38M | 1.24% | -6.22K |
Fidelity Series Growth Company | 1.17M | 1.05% | 1.50K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 08, 2024 | MACARTNEY LAWSON | - | Sell | $137.33K |
Oct 28, 2024 | ZANTE GREG | Chief Financial Officer | Sell | $3.70M |
Oct 28, 2024 | ZANTE GREG | Chief Financial Officer | Sell | $1.41M |
Oct 28, 2024 | ZANTE GREG | Chief Financial Officer | Sell | $712.80K |
Oct 28, 2024 | ZANTE GREG | Chief Financial Officer | Sell | $1.79M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 11 |
2024 Q3 | - | 25 |
2024 Q2 | - | 9 |
2024 Q1 | - | 12 |
2023 Q2 | - | 14 |
VKTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools